Smaio S.A. | Small-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 11.8M
Total Liabilities 4.9M
Shareholders Equity 6.8M
Debt to Equity 0.72

Cash Flow Metrics

Revenue & Profitability Trend

Smaio S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i5.7M7.6M2.4M2.1M1.2M
Cost of Goods Sold i2.4M2.4M2.0M1.5M1.6M
Gross Profit i3.3M5.2M443.6K595.8K-417.3K
Gross Margin % i58.4%68.4%18.2%28.0%-33.9%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i249.6K92.2K123.9K36.2K-84.8K
Total Operating Expenses i249.6K92.2K123.9K36.2K-84.8K
Operating Income i-1.5M736.9K-4.0M-3.4M-2.5M
Operating Margin % i-26.3%9.7%-163.6%-157.8%-201.7%
Non-Operating Items
Interest Income i139.1K128.6K6.6K00
Interest Expense i44.3K35.6K3.5K28.8K16.1K
Other Non-Operating Income-----
Pre-tax Income i-1.4M651.9K2.6M-3.4M-2.5M
Income Tax i-446.4K-406.6K-220.6K-308.5K-277.6K
Effective Tax Rate % i0.0%-62.4%-8.4%0.0%0.0%
Net Income i-933.4K1.1M2.8M-3.1M-2.2M
Net Margin % i-16.3%13.9%116.5%-145.4%-180.5%
Key Metrics
EBITDA i-28.3K2.0M-2.5M-2.3M-1.9M
EPS (Basic) i-€0.18€0.21€0.55-€0.59-€0.43
EPS (Diluted) i-€0.18€0.21€0.55-€0.59-€0.43
Basic Shares Outstanding i52162575215414521001652286515228651
Diluted Shares Outstanding i52162575215414521001652286515228651

Income Statement Trend

Smaio S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i3.2M6.9M5.7M573.8K240.1K
Short-term Investments i-----
Accounts Receivable i1.7M602.5K447.1K382.5K222.7K
Inventory i1.3M1.2M1.4M1.6M1.8M
Other Current Assets-2-2---
Total Current Assets i8.3M10.3M8.5M4.0M3.0M
Non-Current Assets
Property, Plant & Equipment i2.1M1.8M1.5M1.4M886.1K
Goodwill i2.3M2.3M2.3M2.5M2.5M
Intangible Assets i2.3M2.3M2.3M2.5M2.5M
Long-term Investments-----
Other Non-Current Assets-1-1--
Total Non-Current Assets i3.5M3.5M3.5M4.3M3.5M
Total Assets i11.8M13.8M11.9M8.3M6.5M
Liabilities
Current Liabilities
Accounts Payable i1.6M693.5K762.1K559.5K423.4K
Short-term Debt i459.2K379.3K374.6K7.8M6.1M
Current Portion of Long-term Debt-----
Other Current Liabilities--631.9K455.9K334.0K
Total Current Liabilities i3.0M1.4M1.9M8.9M6.9M
Non-Current Liabilities
Long-term Debt i1.8M3.1M00-
Deferred Tax Liabilities i-----
Other Non-Current Liabilities--2---
Total Non-Current Liabilities i1.9M3.1M351.3K00
Total Liabilities i4.9M4.5M2.2M8.9M6.9M
Equity
Common Stock i993.4K993.4K993.4K686.7K3.0M
Retained Earnings i-2.3M-446.2K-251.1K-3.1M-3.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i6.8M9.3M9.7M-618.9K-437.9K
Key Metrics
Total Debt i2.3M3.4M374.6K7.8M6.1M
Working Capital i5.2M8.9M6.6M-4.9M-3.9M

Balance Sheet Composition

Smaio S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-2.3M-446.2K2.8M-3.1M-2.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-1.1M-3.1M642.3K-650.6K-1.9M
Operating Cash Flow i-3.4M-3.6M4.1M-3.7M-4.1M
Investing Activities
Capital Expenditures i-1.6M-1.5M-830.3K-1.3M-1.7M
Acquisitions i00---
Investment Purchases i00---
Investment Sales i34.3K0---
Investing Cash Flow i-1.4M-1.5M-919.3K-1.3M-1.7M
Financing Activities
Share Repurchases i-121.5K-52.7K---
Dividends Paid i-----
Debt Issuance i42.2K2.5M04.1M4.6M
Debt Repayment i-794.7K-131.1K-7.4M-2.4M0
Financing Cash Flow i-839.6K2.4M81.8K4.1M4.7M
Free Cash Flow i-3.0M-1.2M5.1M-3.8M-5.0M
Net Change in Cash i-5.7M-2.7M3.3M-897.6K-1.1M

Cash Flow Trend

Smaio S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 16.30
Forward P/E 28.48
Price to Book 4.98
Price to Sales 6.71
PEG Ratio -0.09

Profitability Ratios

Profit Margin -42.73%
Operating Margin -45.51%
Return on Equity -29.15%
Return on Assets -15.55%

Financial Health

Current Ratio 3.20
Debt to Equity 33.75
Beta 0.74

Per Share Data

EPS (TTM) -€0.18
Book Value per Share €1.32
Revenue per Share €1.05

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alsma36.9M16.304.98-29.15%-42.73%33.75
Equasens 772.6M16.533.3416.13%16.72%25.65
Cegedim S.A 143.2M92.860.54-4.95%-2.25%115.34
Abl Diagnostics 86.8M535.0011.514.00%4.86%34.10
Intrasense S.A 15.2M-9.16-126.47%-251.78%84.95
Ama Corp Plc 14.4M-5.72-176.91%-294.90%159.28

Financial data is updated regularly. All figures are in the company's reporting currency.